Cleo Diagnostics Ltd

A$0.27As of Sun 8 Nov 2026, 12:00 UTC
ASX:COVHealthcare
Country Australia
PE (Fwd) •••
TSR 3Y CAGR 9.87%
Div yield —
ROE (109.48%)
Medical Devices
Beta (5Y) 0.51
PE TTM —
TSR TTM (32.50%)
Mkt cap A$37.02M
ROIC (65.48%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.294
9.02%
221.98%
Hold 8|2|3|12|10
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
0.01
—
8.61%
11.89%
16.39%
15.37%
Revenue$M
2.051
2.063
2.129
2.238
0.53%
1.89%
3.32%
11.19%
Peers (US$25.43M)
Cap (US$)
PE
29.44M
—
Capital
TTM
5Y
10Y
Leveragex
1.112
(0.260)
(0.219)
EBIT/Intx
9.233
0.515
0.536
Own earn%
23.60
136.56
125.15
Sh yield%
31.98
40.77
41.23
Owners
Insiders/Inst%
0.37
57.57
Short interest%
3.05
SBC / revenue%
1.64
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
22
Op margin range%
0–8
$1 testx
−0.5
Incr. ROIC%
9